financetom
Business
financetom
/
Business
/
ARS Pharmaceuticals Says US FDA Approves Lower Dosage of Neffy Nasal Spray
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ARS Pharmaceuticals Says US FDA Approves Lower Dosage of Neffy Nasal Spray
Mar 5, 2025 3:00 PM

05:37 PM EST, 03/05/2025 (MT Newswires) -- ARS Pharmaceuticals ( SPRY ) said the US Food and Drug Administration approved a lower dosage of neffy for allergic emergencies, including anaphylaxis.

The regulator approved a 1 milligram version of the nasal spray for children 4 years and up, the company said Wednesday in a statement.

A 2 mg version of neffy, an epinephrine nasal spray, was approved in the US in 2024.

ARS shares rose 5.1% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved